Dose of Oral Glucose: UK Hypoglycaemia Guide

The dose of oral glucose recommended for treating mild to moderate hypoglycaemia in adults is 15 to 20 grams of fast-acting carbohydrate, taken as soon as low blood sugar is recognised. In UK clinical practice, hypoglycaemia is defined as blood glucose below 4 mmol/L, and oral glucose is the NHS first-line treatment for conscious individuals who can swallow safely. Knowing the correct dose, the right product to use, and when oral glucose is not appropriate can make a significant difference to outcomes for people with diabetes and those who support them.

What is oral glucose and when is it used in the UK?

Oral glucose is a fast-acting carbohydrate used as the NHS first-line treatment for mild to moderate hypoglycaemia in conscious adults when blood glucose falls below 4 mmol/L. It is most commonly needed by people with diabetes using insulin or sulfonylureas.

Oral glucose is a fast-acting carbohydrate taken by mouth to raise blood sugar levels quickly in people experiencing hypoglycaemia (low blood sugar). In UK clinical practice, hypoglycaemia is treated when blood glucose falls below 4 mmol/L, a threshold supported by NHS and Diabetes UK guidance and sometimes expressed as the reminder "4 is the floor".^[1][3] Hypoglycaemia is most commonly encountered in people with diabetes who use insulin or certain other glucose-lowering medicines such as sulfonylureas.

Glucose is a simple sugar that is absorbed rapidly from the gut into the bloodstream, making it particularly effective at reversing the symptoms of a hypoglycaemic episode. Unlike complex carbohydrates, which require digestion before they can raise blood glucose, pure glucose begins to act within minutes of being swallowed.

In the UK, the NHS recommends oral glucose as the first-line treatment for mild to moderate hypoglycaemia in conscious individuals who are able to swallow safely.^[1][2] It is used in a wide range of settings, including at home, in schools, in the workplace, and in primary and secondary care. People with diabetes, their carers, and those who support them are encouraged to keep a source of fast-acting glucose readily available at all times.

It is worth noting that hypoglycaemia caused by sulfonylureas can be prolonged and recurrent, because these medicines continue to stimulate insulin release for several hours.^[3] Even after initial recovery, people on sulfonylureas should seek medical review to ensure blood glucose remains stable. People who use a continuous glucose monitor (CGM) should be aware that sensor readings can lag behind actual blood glucose during a rapid fall; where possible, confirm a suspected low with a capillary finger-prick test before treating.

Oral glucose is distinct from glucagon, which is an injectable or nasal treatment reserved for severe hypoglycaemia where the person is unconscious or unable to swallow. Understanding when each treatment is appropriate is an important part of diabetes self-management education, which is supported in the UK through structured programmes such as DESMOND and DAFNE.

How much oral glucose should you take to treat low blood sugar?

Adults should take 15 to 20 grams of fast-acting carbohydrate, then recheck blood glucose after 10 to 15 minutes, repeating the dose if levels remain below 4 mmol/L. Children require a lower, weight-based dose determined by their diabetes care team.

The standard recommended dose of oral glucose for treating mild to moderate hypoglycaemia in adults is 15 to 20 grams of fast-acting carbohydrate, taken as soon as low blood sugar is recognised.^[1][2] This guidance is consistent with NHS and Diabetes UK recommendations. Take 15 to 20 grams of fast-acting glucose, wait 10 to 15 minutes, then recheck blood glucose. If blood glucose remains below 4 mmol/L after 10 to 15 minutes, the same dose should be repeated. Once blood glucose has returned to a safe level (generally 4 mmol/L or above), a longer-acting carbohydrate snack, such as a biscuit or a small sandwich, should be eaten to help maintain stable levels and prevent a further dip.

If you use a CGM, confirm a low reading with a finger-prick capillary test before treating where this is feasible, as sensor readings can lag during a rapid fall in blood glucose.

For children, the dose is lower and is typically calculated according to body weight. Healthcare professionals, including paediatric diabetes nurses and GPs, will advise on the appropriate amount for individual children. Parents and carers should follow the specific guidance given by the child's diabetes care team rather than applying adult doses. NICE guidance for children and young people with diabetes (NG18) provides the framework for paediatric hypoglycaemia management.^[6]

It is important not to over-treat hypoglycaemia by taking excessive amounts of glucose, as this can lead to rebound hyperglycaemia (high blood sugar). Keeping a blood glucose meter to hand allows accurate monitoring before and after treatment. People who experience frequent or severe hypoglycaemic episodes should discuss this with their GP or diabetes specialist, as it may indicate that their medication regimen needs review.

What forms of oral glucose are available and how do they differ?

Glucose tablets, gels such as GlucoGel, and sugary drinks all provide fast-acting carbohydrate, but differ in speed of absorption, portability, and suitability. People taking acarbose must use pure dextrose-based products, as acarbose blocks the breakdown of sucrose.

Several forms of oral glucose are available in the UK, each delivering a measured amount of fast-acting carbohydrate, though they differ in convenience, palatability, and speed of absorption. The most commonly used products include glucose tablets (such as Dextro Energy or GlucoTabs), glucose gels (such as GlucoGel, formerly known as Hypostop), glucose drinks, and ordinary sugary foods or drinks.

Glucose tablets are a popular choice because they are portable, easy to dose accurately, and have a long shelf life. The carbohydrate content per tablet varies between brands, so always check the nutrition label to confirm how many grams of carbohydrate each tablet provides and calculate how many tablets are needed to reach 15 to 20 grams. Glucose gels are particularly useful when a person is drowsy or has difficulty chewing; the gel can be squeezed into the mouth, though they should only be used in people who are conscious and able to swallow safely.

Sugary drinks such as fruit juice (approximately 150 to 200 ml of orange juice) or non-diet fizzy drinks can also provide a suitable dose of fast-acting carbohydrate, though the exact glucose content varies by product. Milk, while containing lactose, is absorbed more slowly and is generally less suitable as a first-line treatment for acute hypoglycaemia.

An important caution: people taking acarbose (an alpha-glucosidase inhibitor used in type 2 diabetes) must treat hypoglycaemia with pure glucose or dextrose rather than sucrose-containing products such as ordinary sugary drinks or sweets. Acarbose blocks the enzyme that breaks down sucrose into glucose, so sucrose-based treatments will not work quickly enough. Glucose tablets or gels containing dextrose are appropriate; check the product label to confirm the carbohydrate source.

Chocolate and biscuits, although they contain sugar, also contain fat, which slows glucose absorption and makes them less effective for rapid treatment. They are better used as the follow-up longer-acting snack. People should check product labels carefully to ensure they are selecting a source that delivers the correct amount of glucose.

Are there situations where oral glucose is not safe to use?

Oral glucose must not be given to anyone who is unconscious, having a seizure, or unable to swallow safely, due to the risk of aspiration. In these situations, injectable or nasal glucagon should be used and 999 called if needed.

Oral glucose is not safe to use when a person is unconscious, severely drowsy, having a seizure, or otherwise unable to swallow safely, because of the significant risk of choking or aspiration. In these situations, oral glucose must not be given, and emergency treatment with injectable glucagon (such as GlucaGen) or nasal glucagon (Baqsimi) should be used instead. If glucagon is unavailable or ineffective, emergency services should be called by dialling 999. Any severe hypoglycaemic episode that requires assistance from another person warrants urgent clinical review on the same day, particularly for people taking sulfonylureas, because of the risk of recurrence.

People with certain swallowing difficulties (dysphagia), including those who have had a stroke or who have neurological conditions affecting swallowing, may also be unable to take oral glucose safely. In these cases, the diabetes care team should provide an individualised hypoglycaemia management plan that accounts for the person's specific needs.

Oral glucose should be used with caution in people with conditions that affect carbohydrate absorption, such as certain gastrointestinal disorders, though these situations are uncommon and should be discussed with a specialist. People with type 1 glycogen storage disease (von Gierke disease) require specific medical guidance on glucose management and should not self-treat without specialist input.

For people who are pregnant and have diabetes, hypoglycaemia management remains broadly the same, but the target blood glucose range and the frequency of monitoring may differ. Pregnant women with diabetes should follow the individualised guidance provided by their obstetric diabetes team, in line with NICE guidance on diabetes in pregnancy (NG3). Similarly, people with renal impairment or other complex comorbidities should ensure their hypoglycaemia management plan is reviewed regularly by their healthcare team to account for any changes in their condition or medication.

Side effects and warnings: what to watch for after taking oral glucose

Rebound hyperglycaemia from over-treatment is the most common concern; rechecking blood glucose 10 to 15 minutes after each dose helps avoid this. Recurrent hypoglycaemia or any episode requiring assistance warrants prompt review by a GP or diabetes nurse.

Oral glucose is generally well tolerated when taken in the recommended amounts, but there are several side effects and warning signs that people should be aware of. The most common issue following treatment is rebound hyperglycaemia, which occurs when too much glucose is taken or when blood glucose is not rechecked after treatment. Symptoms of high blood sugar include increased thirst, frequent urination, and fatigue. Checking blood glucose 10 to 15 minutes after treatment and again after the follow-up snack helps to avoid this.

Nausea is occasionally reported after taking glucose tablets or gels, particularly if taken on an empty stomach or in large quantities. This is usually mild and short-lived. Some glucose products contain additives such as flavourings or sweeteners that may cause gastrointestinal discomfort in sensitive individuals; checking the product ingredients can help identify potential triggers.

If blood glucose does not recover after two or three treatment cycles, or if symptoms worsen rather than improve, this may indicate a more severe episode or an underlying problem with glucose regulation. In this situation, emergency services should be called by dialling 999. NHS 111 can provide urgent advice if symptoms are concerning but not immediately life-threatening.

People who experience recurrent hypoglycaemia, or any episode that required assistance from another person, should speak to their GP or diabetes nurse promptly, as this may signal that their insulin or medication dose needs adjustment. This is particularly important for people on sulfonylureas, where recurrent episodes can indicate a need for dose reduction or medication change. People should also be aware that certain medicines, including beta-blockers, can mask some of the warning symptoms of hypoglycaemia, making regular monitoring and ongoing diabetes education especially important.^[11]

Suspected adverse reactions to glucose-containing products can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Keeping a record of hypoglycaemic episodes, including the time, blood glucose reading, and amount of glucose taken, can be a valuable tool when discussing management with a healthcare professional.

People with diabetes who drive and who are treated with insulin or sulfonylureas should follow DVLA guidance on fitness to drive after a hypoglycaemic episode. The DVLA publishes specific advice for people with diabetes in its guidance document "Assessing fitness to drive", which is available on the GOV.UK website.

Scientific References

1. Low blood sugar (hypoglycaemia).
2. Glucose | Drugs – BNF – NICE.
3. Hypoglycaemia | Treatment summaries – BNF – NICE.
4. Acarbose | Drugs – BNF – NICE.
5. Baqsimi | European Medicines Agency (EMA).
6. Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18).
7. Diabetes in pregnancy: management from preconception to the postnatal period (NG3).
8. Structured education programme | Type 2 diabetes in adults (QS209).
9. Diabetes mellitus: assessing fitness to drive.
10. Diabetes and driving.
11. Beta Blockers can Mask not only Hypoglycemia but also… Koracevic G et al..
12. Hypoglycaemia: Initial Advice on How to Treat Low Blood Glucose Levels.

Frequently Asked Questions